USD 154.07
(-1.97%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 739.87 Million USD | 1.73% |
2022 | 697.76 Million USD | 41.97% |
2021 | 491.49 Million USD | 6.5% |
2020 | 461.49 Million USD | -2.2% |
2019 | 471.86 Million USD | -17.22% |
2018 | 570.02 Million USD | 33.78% |
2017 | 426.09 Million USD | 111.57% |
2016 | 201.39 Million USD | 11.39% |
2015 | 180.79 Million USD | 19.42% |
2014 | 151.4 Million USD | -2.15% |
2013 | 154.73 Million USD | -1.14% |
2012 | 156.51 Million USD | 9.94% |
2011 | 142.35 Million USD | 9.01% |
2010 | 130.59 Million USD | 20.01% |
2009 | 108.81 Million USD | 21.16% |
2008 | 89.81 Million USD | 14.79% |
2007 | 78.24 Million USD | -3.03% |
2006 | 80.68 Million USD | 16.25% |
2005 | 69.4 Million USD | 94.43% |
2004 | 35.69 Million USD | -39.4% |
2003 | 58.91 Million USD | 14.74% |
2002 | 51.34 Million USD | 27.96% |
2001 | 40.12 Million USD | 8.39% |
2000 | 37.01 Million USD | 19.41% |
1999 | 31 Million USD | 21.57% |
1998 | 25.5 Million USD | 29.44% |
1997 | 19.7 Million USD | 21.6% |
1996 | 16.2 Million USD | 26.56% |
1995 | 12.8 Million USD | 45.45% |
1994 | 8.8 Million USD | 17.33% |
1993 | 7.5 Million USD | 4.17% |
1992 | 7.2 Million USD | 35.85% |
1991 | 5.3 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 205.73 Million USD | 13.19% |
2024 Q1 | 183.26 Million USD | 16.13% |
2023 FY | 709.81 Million USD | 1.73% |
2023 Q1 | 192.04 Million USD | 9.77% |
2023 Q4 | 157.8 Million USD | -14.2% |
2023 Q3 | 183.92 Million USD | -4.37% |
2023 Q2 | 192.32 Million USD | 0.15% |
2022 Q2 | 167.59 Million USD | -0.73% |
2022 FY | 697.76 Million USD | 41.97% |
2022 Q4 | 174.94 Million USD | -6.14% |
2022 Q3 | 186.39 Million USD | 11.22% |
2022 Q1 | 168.82 Million USD | 32.42% |
2021 Q2 | 123.52 Million USD | 9.63% |
2021 Q3 | 127.79 Million USD | 3.45% |
2021 FY | 491.49 Million USD | 6.5% |
2021 Q4 | 127.49 Million USD | -0.24% |
2021 Q1 | 112.68 Million USD | -6.0% |
2020 FY | 461.49 Million USD | -2.2% |
2020 Q1 | 121.41 Million USD | 6.37% |
2020 Q2 | 106.28 Million USD | -12.46% |
2020 Q3 | 113.92 Million USD | 7.19% |
2020 Q4 | 119.87 Million USD | 5.22% |
2019 Q3 | 118.55 Million USD | 14.14% |
2019 Q4 | 114.14 Million USD | -3.72% |
2019 Q2 | 103.86 Million USD | -23.23% |
2019 FY | 471.86 Million USD | -17.22% |
2019 Q1 | 135.3 Million USD | 0.49% |
2018 Q4 | 134.64 Million USD | 0.04% |
2018 Q1 | 149 Million USD | 8.37% |
2018 Q2 | 151.8 Million USD | 1.88% |
2018 Q3 | 134.58 Million USD | -11.34% |
2018 FY | 570.02 Million USD | 33.78% |
2017 Q1 | 88.94 Million USD | 75.23% |
2017 Q4 | 137.49 Million USD | 23.2% |
2017 Q3 | 111.59 Million USD | 26.73% |
2017 Q2 | 88.06 Million USD | -0.99% |
2017 FY | 426.09 Million USD | 111.57% |
2016 Q2 | 50.13 Million USD | 1.83% |
2016 FY | 201.39 Million USD | 11.39% |
2016 Q4 | 50.76 Million USD | -1.0% |
2016 Q3 | 51.27 Million USD | 2.28% |
2016 Q1 | 49.23 Million USD | 2.02% |
2015 FY | 180.79 Million USD | 19.42% |
2015 Q4 | 48.25 Million USD | 4.31% |
2015 Q1 | 42.51 Million USD | 7.13% |
2015 Q3 | 46.26 Million USD | 5.72% |
2015 Q2 | 43.76 Million USD | 2.93% |
2014 Q3 | 38.14 Million USD | 1.61% |
2014 FY | 151.4 Million USD | -2.15% |
2014 Q1 | 36.02 Million USD | -7.49% |
2014 Q2 | 37.54 Million USD | 4.21% |
2014 Q4 | 39.68 Million USD | 4.03% |
2013 Q4 | 38.94 Million USD | -4.91% |
2013 Q3 | 40.95 Million USD | 7.67% |
2013 Q2 | 38.03 Million USD | 3.38% |
2013 Q1 | 36.79 Million USD | -11.91% |
2013 FY | 154.73 Million USD | -1.14% |
2012 FY | 156.51 Million USD | 9.94% |
2012 Q2 | 39.08 Million USD | 11.77% |
2012 Q3 | 40.69 Million USD | 4.13% |
2012 Q4 | 41.76 Million USD | 2.64% |
2012 Q1 | 34.96 Million USD | -2.75% |
2011 Q2 | 36.2 Million USD | 4.55% |
2011 FY | 142.35 Million USD | 9.01% |
2011 Q4 | 35.95 Million USD | 1.07% |
2011 Q3 | 35.57 Million USD | -1.73% |
2011 Q1 | 34.62 Million USD | -7.68% |
2010 Q1 | 26.92 Million USD | -14.28% |
2010 Q4 | 37.5 Million USD | 10.21% |
2010 FY | 130.59 Million USD | 20.01% |
2010 Q3 | 34.03 Million USD | 5.93% |
2010 Q2 | 32.12 Million USD | 19.31% |
2009 Q4 | 31.41 Million USD | 25.41% |
2009 FY | 108.81 Million USD | 21.16% |
2009 Q1 | 26.56 Million USD | 1.03% |
2009 Q2 | 25.78 Million USD | -2.92% |
2009 Q3 | 25.04 Million USD | -2.87% |
2008 FY | 89.81 Million USD | 14.79% |
2008 Q4 | 26.29 Million USD | 5.4% |
2008 Q2 | 20.8 Million USD | 17.07% |
2008 Q1 | 17.77 Million USD | -6.58% |
2008 Q3 | 24.94 Million USD | 19.91% |
2007 Q2 | 20.63 Million USD | 7.4% |
2007 FY | 78.24 Million USD | -3.03% |
2007 Q1 | 19.21 Million USD | 10.37% |
2007 Q4 | 19.02 Million USD | -1.77% |
2007 Q3 | 19.36 Million USD | -6.16% |
2006 Q1 | 21.35 Million USD | 14.97% |
2006 Q3 | 18.85 Million USD | -18.31% |
2006 Q4 | 17.41 Million USD | -7.64% |
2006 FY | 80.68 Million USD | 16.25% |
2006 Q2 | 23.07 Million USD | 8.07% |
2005 Q2 | 16.33 Million USD | 7.28% |
2005 FY | 69.4 Million USD | 94.43% |
2005 Q4 | 18.57 Million USD | -3.66% |
2005 Q1 | 15.22 Million USD | 224.01% |
2005 Q3 | 19.27 Million USD | 18.02% |
2004 Q2 | 12.06 Million USD | -2.87% |
2004 Q3 | 6.51 Million USD | -46.0% |
2004 Q1 | 12.42 Million USD | -25.83% |
2004 FY | 35.69 Million USD | -39.4% |
2004 Q4 | 4.69 Million USD | -27.86% |
2003 Q1 | 17.75 Million USD | 25.95% |
2003 FY | 58.91 Million USD | 14.74% |
2003 Q4 | 16.74 Million USD | 36.38% |
2003 Q2 | 12.13 Million USD | -31.64% |
2003 Q3 | 12.27 Million USD | 1.18% |
2002 Q2 | 13.33 Million USD | 7.99% |
2002 FY | 51.34 Million USD | 27.96% |
2002 Q4 | 14.09 Million USD | 21.88% |
2002 Q3 | 11.56 Million USD | -13.29% |
2002 Q1 | 12.34 Million USD | 1.5% |
2001 Q3 | 9.34 Million USD | -7.1% |
2001 Q2 | 10.06 Million USD | 4.39% |
2001 Q4 | 12.16 Million USD | 30.16% |
2001 Q1 | 9.63 Million USD | -12.95% |
2001 FY | 40.12 Million USD | 8.39% |
2000 Q2 | 9.2 Million USD | -2.82% |
2000 Q4 | 11.07 Million USD | 61.14% |
2000 FY | 37.01 Million USD | 19.41% |
2000 Q1 | 9.46 Million USD | -0.34% |
2000 Q3 | 6.87 Million USD | -25.32% |
1999 Q4 | 9.5 Million USD | 39.71% |
1999 Q2 | 7.4 Million USD | 1.37% |
1999 FY | 31 Million USD | 21.57% |
1999 Q3 | 6.8 Million USD | -8.11% |
1999 Q1 | 7.3 Million USD | 17.74% |
1998 Q3 | 6.3 Million USD | -4.55% |
1998 Q1 | 6.4 Million USD | 14.29% |
1998 FY | 25.5 Million USD | 29.44% |
1998 Q4 | 6.2 Million USD | -1.59% |
1998 Q2 | 6.6 Million USD | 3.13% |
1997 Q3 | 5 Million USD | 8.7% |
1997 Q2 | 4.6 Million USD | 2.22% |
1997 Q1 | 4.5 Million USD | -2.17% |
1997 FY | 19.7 Million USD | 21.6% |
1997 Q4 | 5.6 Million USD | 12.0% |
1996 Q2 | 3.8 Million USD | -7.32% |
1996 FY | 16.2 Million USD | 26.56% |
1996 Q3 | 3.6 Million USD | -5.26% |
1996 Q4 | 4.6 Million USD | 27.78% |
1996 Q1 | 4.1 Million USD | 13.89% |
1995 Q3 | 2.7 Million USD | -27.03% |
1995 Q4 | 3.6 Million USD | 33.33% |
1995 Q2 | 3.7 Million USD | 27.59% |
1995 FY | 12.8 Million USD | 45.45% |
1995 Q1 | 2.9 Million USD | 31.82% |
1994 FY | 8.8 Million USD | 17.33% |
1994 Q1 | 2.7 Million USD | 0.0% |
1994 Q2 | 2.2 Million USD | -18.52% |
1994 Q3 | 1.5 Million USD | -31.82% |
1994 Q4 | 2.2 Million USD | 46.67% |
1993 FY | 7.5 Million USD | 4.17% |
1993 Q4 | 2.7 Million USD | 107.69% |
1993 Q3 | 1.3 Million USD | -13.33% |
1993 Q2 | 1.5 Million USD | -25.0% |
1993 Q1 | 2 Million USD | 5.26% |
1992 Q1 | 1.8 Million USD | 0.0% |
1992 Q2 | 1.7 Million USD | -5.56% |
1992 Q3 | 1.8 Million USD | 5.88% |
1992 Q4 | 1.9 Million USD | 5.56% |
1992 FY | 7.2 Million USD | 35.85% |
1991 Q1 | 1.9 Million USD | 0.0% |
1991 FY | 5.3 Million USD | 0.0% |
1991 Q2 | 1.9 Million USD | 0.0% |
1991 Q3 | 1.9 Million USD | 0.0% |
1991 Q4 | 1.8 Million USD | -5.26% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Akoya Biosciences, Inc. | 56.3 Million USD | -1214.045% |
AngioDynamics, Inc. | 154.69 Million USD | -378.269% |
AtriCure, Inc. | 300.37 Million USD | -146.321% |
Avinger, Inc. | 2 Million USD | -36838.243% |
Azenta, Inc. | 263.14 Million USD | -181.171% |
BioLife Solutions, Inc. | 46.75 Million USD | -1482.548% |
The Cooper Companies, Inc. | 2.35 Billion USD | 68.622% |
Daxor Corporation | 1.1 Million USD | -66951.494% |
Ekso Bionics Holdings, Inc. | 9.07 Million USD | -8049.279% |
Femasys Inc. | 691.9 Thousand USD | -106833.362% |
GlucoTrack, Inc. | -13 Thousand USD | 5691430.769% |
Harvard Bioscience, Inc. | 60.86 Million USD | -1115.577% |
Hologic, Inc. | 2.22 Billion USD | 66.789% |
Intuitive Surgical, Inc. | 4.72 Billion USD | 84.356% |
KORU Medical Systems, Inc. | 16.7 Million USD | -4328.181% |
LeMaitre Vascular, Inc. | 127.04 Million USD | -482.352% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 620127.822% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 620127.822% |
Masimo Corporation | 1 Billion USD | 26.271% |
Microbot Medical Inc. | -106 Thousand USD | 698093.396% |
Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -2135.603% |
Merit Medical Systems, Inc. | 583.87 Million USD | -26.718% |
Nephros, Inc. | 8.4 Million USD | -8702.772% |
NovoCure Limited | 381.05 Million USD | -94.163% |
NEXGEL, Inc. | 619 Thousand USD | -119427.141% |
NEXGEL, Inc. | 619 Thousand USD | -119427.141% |
Singular Genomics Systems, Inc. | -558 Thousand USD | 132693.728% |
OraSure Technologies, Inc. | 179.42 Million USD | -312.367% |
Pro-Dex, Inc. | 14.55 Million USD | -4984.688% |
Pulse Biosciences, Inc. | -1.2 Million USD | 61398.509% |
Predictive Oncology Inc. | 1.14 Million USD | -64500.972% |
Precision Optics Corporation, Inc. | 5.79 Million USD | -12661.322% |
QuidelOrtho Corporation | 1.49 Billion USD | 50.49% |
Repligen Corporation | 315.22 Million USD | -134.71% |
Sanara MedTech Inc. | 57.13 Million USD | -1194.907% |
STAAR Surgical Company | 252.65 Million USD | -192.844% |
Sharps Technology, Inc. | -891.24 Thousand USD | 83115.39% |
Utah Medical Products, Inc. | 30.03 Million USD | -2363.123% |
DENTSPLY SIRONA Inc. | 2.08 Billion USD | 64.531% |
Jin Medical International Ltd. | 6.78 Million USD | -10804.806% |